ロード中...
Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma
GOALS AND BACKGROUND: Clinical staging with endoscopic ultrasound (EUS) and positron emission tomography (PET) is used to identify esophageal adenocarcinoma (EAC) patients with locally advanced disease and therefore, benefit from neoadjuvant therapy. However, EUS is operator dependent and subject to...
保存先:
| 出版年: | J Clin Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2022
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8255331/ https://ncbi.nlm.nih.gov/pubmed/33405434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001489 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|